Il Dong Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
Il Dong Pharmaceutical Co Ltd cash flow-to-debt ratio. Il Dong Pharmaceutical Co Ltd (249420) has a Cash Flow-to-Debt Ratio of 0.03x as of September 2025, meaning its operating cash flow of ₩11.28 Billion could theoretically repay 0% of its total liabilities (₩347.04 Billion) in one year. Check Il Dong Pharmaceutical Co Ltd (249420) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Il Dong Pharmaceutical Co Ltd (2016–2024)
Cash flow-to-debt ratio of Il Dong Pharmaceutical Co Ltd from 2016 to 2024. Historical debt coverage capacity for Il Dong Pharmaceutical Co Ltd across 9 annual periods. Check 249420 cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Il Dong Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (2016–2024)
Il Dong Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 2016 to 2024. Year-by-year debt coverage analysis for Il Dong Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see cash efficiency ratio of Il Dong Pharmaceutical Co Ltd.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.07x | ₩28.29 Billion | ₩429.99 Billion | ▲ +178.5% |
| 2023 | -0.08x | ₩-36.62 Billion | ₩437.00 Billion | ▲ +28.4% |
| 2022 | -0.12x | ₩-53.54 Billion | ₩457.59 Billion | ▼ -464.5% |
| 2021 | -0.02x | ₩-11.37 Billion | ₩548.39 Billion | ▼ -137.5% |
| 2020 | 0.06x | ₩19.37 Billion | ₩350.73 Billion | ▼ -52.0% |
| 2019 | 0.11x | ₩41.37 Billion | ₩359.83 Billion | ▼ -50.3% |
| 2018 | 0.23x | ₩66.65 Billion | ₩287.84 Billion | ▼ -12.2% |
| 2017 | 0.26x | ₩73.72 Billion | ₩279.55 Billion | ▲ +61.7% |
| 2016 | 0.16x | ₩45.98 Billion | ₩281.94 Billion | — |